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1. Introduction
The importance of structural biology has been highlighted in the past few years not only as
part of drug discovery programs in the pharmaceutical industry but also by structural ge‐
nomics programs. Although the function of a protein can be studied by several biochemical
and or biophysical techniques a molecular understanding of a protein can only be obtained
by combining functional data with the three-dimensional structure. In principle three tech‐
niques exist to determine a protein structure, namely X-ray crystallography, nuclear mag‐
netic resonance (NMR) and electron microscopy (EM). X-ray crystallography contributes
over 90 % of all structures in the protein data bank (PDB) and emphasis the importance of
this technique. Crystallization of a protein is a tedious route and although a lot of knowl‐
edge about crystallization has been gained in the last decades, one still cannot predict the
outcome. The sometimes unexpected bottlenecks in protein purification and crystallization
have recently been summarized and possible strategies to obtain a protein crystal were
postulated [1]. This book chapter will tackle the next step: How to crystallize protein-ligand
complexes or intermediate steps of the reaction cycle?
A single crystal structure of a protein however, is not enough to completely understand the
molecular function. Conformational changes induced by for example ligand binding cannot
be anticipated a priori. The determination of particular structures of one protein, for example
with bound ligand(s) is required to visualize the different states within a reaction cycle. Ide‐
ally, one would trap an open conformation without any ligand, an open ligand-bound and a
closed form with the bound molecule as well as the closed ligand-free protein to visualize
the conformational changes occurring during catalysis in detail.
Within this chapter, the structural conformational changes induced by ligand binding with
respect to the methods chosen for the crystallization are described. Here three distinct pro‐
tein families are exemplarily described: first, where one substrate or ligand is bound, sec‐
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ond, a protein with two or more bound substrates and finally, the structures of proteins, in
which the product of the reaction cycle is present in the active site.
Specific methods or expressions written in bold italics are explained in the glossary box at
the end of the chapter.
1.1. General approaches to obtain crystals with bound ligands and how to prepare the
ground
Often the knowledge of the structure of a protein or enzyme without bound ligand(s) is not
sufficiently significant since there is no or only little information provided about the catalyt‐
ic mechanism. To gain further insights, it is important or at least helpful to obtain a binary
or ternary structure of the protein of interest.
In theory there are different approaches to reach this goal even though it can be a difficult
task in reality. All of them have in common that the naturally catalysed reaction must not
occur. Apart from reporting all possible attempts we would like to give a general overview
about several co-crystallization/soaking strategies first, followed by selected examples de‐
scribed within this bookchapter.
Possible co-crystallization or soaking trials:
(In order to keep it simple and coherent the expression „ligand“ in the following paragraph
is used in terms of „substrate“, „cofactor“ or „binding partner“.)
• first ligand without second ligand
• second ligand without first ligand
• first ligand with product of the second ligand
• product of the first ligand with second ligand
• substrate analogue/inhibitor or non-hydrolysable cofactor
• application of substances that mimic transition state products (e. g. AlF3 which imitates a
phosphate group)
• usage of catalytically inactive mutants with bound ligand(s)
• creation of an environment (i. g. buffer condition) which shifts the equilibrium constant
so that the reaction cannot occur
The most important point concerning preparing co-crystallization trials is the knowledge of
the corresponding kinetical parameters. Proteins bind their natural ligand(s) with high af‐
finity, which means in the nM- up to low mM range. To successfully crystallize a protein
with the ligand(s) bound, the affinity needs to be determined. There are numerous biophysi‐
cal techniques to achieve this, for example Intrinsic Tryptophan Fluorescence, Isothermal
Calorimetry, Surface Plasmon Resonance and many others. In principle the affinity is de‐
termined by the size of a ligand as well as the property of the binding site of the protein. As
first approximation, one can state that affinity increases with a decrease in ligand size.
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The application of a too low concentration of the ligand can lead to an inhomogeneous pro‐
tein solution, which means that not all of the protein molecules are loaded with ligand (and
this can prevent crystallization). It is also possible, that a low level of occupancy causes an
undefined electron density so that the ligand cannot be placed or which even makes a struc‐
ture solution impossible. As a rule of thumb the concentration of the ligand(s) should be ap‐
plied to the crystallization trial about 5-fold of the corresponding KM value (the Michaelis
constant KM is the substrate concentration at which the reaction rate is half of Vmax, which
represents the maximum rate achieved by the system, at maximum (saturating) substrate
concentrations).
Beyond that all requirements for the protein solution itself remain valid as described in [1]
in more detail.
2. Binding protein with one ligand – How to crystallize and what can be
deduced from the structure
A typical class of a protein binding one ligand are substrate-binding proteins (SBPs), and
substrate-binding domains (SBDs) [2]. They form a class of proteins (or protein domains)
that are often associated with membrane protein complexes for transport or signal transduc‐
tion. SBPs were originally found to be associated with prokaryotic ATP binding cassette
(ABC)-transporters, but have more recently been shown to be part of other membrane pro‐
tein complexes as well such as prokaryotic tripartite ATP-independent periplasmic (TRAP)-
transporters, prokaryotic two-component regulatory systems, eukaryotic guanylate cyclase-
atrial natriuretic peptide receptors, G-protein coupled receptors (GPCRs) and ligand-gated
ion channels [2].
Structural studies of a substantial number of SBPs revealed a common fold with a bilobal
organization connected via a linker region [2]. In the ligand-free, open conformation, the
two lobes or domains are separated from each other, thereby forming a deep, solvent ex‐
posed cleft, which harbors the substrate-binding site. Upon ligand binding, both domains of
the SBP move towards each other through a hinge-bending motion or rotation, which results
in the so-called liganded-closed conformation. As a consequence of this movement, residues
originating from both domains generate the ligand-binding site and trap the ligand deeply
within the SBP [3]. In the absence of a ligand, unliganded-open and unliganded-closed
states of the SBP are in equilibrium, and the ligand solely shifts this equilibrium towards the
liganded-closed state. This sequence of events has been coined the “Venus-fly trap mecha‐
nism” [4-6]; it is supported by a number of crystal structures in the absence and presence of
a ligand [7, 8] and other biophysical techniques [3].
For the maltose binding protein (MBP) from Escherichia coli [9], it has been shown that both
domains are dynamically fluctuating around an average orientation in the absence of the li‐
gand [10]. NMR spectroscopy of MBP in solution revealed that the ligand-free form of MBP
consists of a predominantly open species (95 %) and a minor species (5 %) that corresponds
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to a partially closed state; both forms co-exist in rapid equilibrium [11]. The open form of
MBP observed by NMR is similar to the crystal structure of the unliganded-open conforma‐
tion [12]. However, the partially closed species detected by NMR [11] does not correspond
to the ligand-bound, fully closed form found in crystallographic studies. Instead, it repre‐
sents an intermediate, partially closed conformation [13], suggesting that the substrate is re‐
quired to reach the final, liganded-closed conformation.
Upon substrate binding, the closed conformation is stabilized, and the ligand is trapped with‐
in a cleft in between the two domains [14-16]. In principle one can divide the conformational
changes in four (I-IV) states (highlighted in Figure 1). State I is the „open-unliganded“ where
the protein adopts an open conformation and no substrate is bound to the protein. State II is the
„closed-liganded“ conformation where the substrate is bound and induced a conformational
change of both domains towards each other. This is likely the state within the cell before deliv‐
ery of the substrate to its cognate transporter. Two other states are known to be present in solu‐
tion although less  frequent  and the equilibrium is  shifted towards the open-unliganded
conformation. These forms are state III, the „closed-unliganded“ state and state IV, the „semi-
closed-unliganded“ state. These are unfavorable conformations of the SBP, which occur due to
the flexibility of the linker region in between both domains.
Figure 1. Substrate binding proteins exist in four major conformations: I) unliganded-open II) liganded-closed III) unli‐
ganded-closed and IV) unliganded-semi-open. All states are in equilibrium with each other. In solution states I and II
occur most frequently. To fully understand the opening and closing mechanism of the protein however snapshots of
every state are needed to gain full knowledge.
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To fully understand the function as well as the structural changes happening upon ligand/
substrate binding it would require structural information of at least states I and II, prefera‐
bly also of states III and IV.
2.1. Crystallization of the open-unliganded conformation (state I)
The crystallization of an open conformation of a rather flexible protein is not straight for‐
ward and most of the success came from „trial-and-error“ approaches. After purification of
the protein, a reasonable concentration of the protein is taken to set up crystallization trials.
Most commonly the vapor diffusion method with the hanging or sitting drop is used. SBPs
mainly exist in the open-unliganded conformation in the absence of the substrate whereas
only a small fraction is in a closed-unliganded conformation [5, 11, 17]. Thus, basically a
standard crystallization approach is used to obtain crystals suitable for structure determina‐
tion. This is reflected by the large number of structures solved in the unliganded-open con‐
formation (see [2] for a recent summary of the available SBP structures). The open
conformation basically gives an overall picture of the protein structures and in the case of
SBPs the bilobal fold of the protein can be observed. In this conformation the binding site of
the substrate is laid open and a detailed picture on how the substrate is bound cannot be
deduced.
Most of the times the open conformation crystallizes differently from the ligand bound state.
This is reflected in the different crystallization conditions as well as in changes of the crystal
parameters (unit cell and/or spacegroup). One example is given below for the glycine be‐
taine binding protein ProX.
2.2. Crystallization of the substrate bound closed conformation (state II)
The vast majority of substrate binding proteins have been crystallized in the closed-ligand
bound conformation (for a detailed list see [2]). This is mainly due to the fact that the sub‐
strate bound protein adopts a stable conformation and possesses a drastically reduced in‐
trinsic flexibility. In principle there are four methods to include the substrate into the
crystallization trials: 1) co-crystallization 2) ligand soaking 3) micro or macro seeding 4) en‐
dogenously bound ligands.
The first method is co-crystallization. Here, normally the substrate is added prior to crystal‐
lization to the protein solution. As listed in Table 1 this is the method used the most in SBP
crystallization trials. Knowledge about the affinity of the ligand is important, since the bilo‐
bal SPBs exist in equilibrium between the open and closed state in solution and the addition
of substrate directs this equilibrium towards the latter. Exemplary, 11 SBPs are listed in Ta‐
ble 1 where the affinity of the corresponding ligand(s) as well as the concentration used in
the crystallization trials is highlighted. In principle the concentrations used are 10-1000
times above the Kd.
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Protein Organism Ligand(s) Open- un-
liganded
Closed-
liganded
Reso-
lution
(Å)
Max.
affinity
Used
Conc.
Method Ref.
BtuF E. coli vitamin B12 Y Y 2 15 nM 5 mM 1 [18]
Lbp S. pyogenes zinc - Y 2.45 ~10 µM - 4 [19]
GGBP S. typhimurium D-glucose Y Y 1.9 0.5 µM 3 mM 1 [20]
MBP E. coli Oligo-sacharide Y Y 1.67 0.16 µM 2 mM 1 [21]
RBP E. coli D-ribose Y Y 1.6 0.13 µM 1 mM 1
OppA L. lactis Oligo-peptide Y Y 1.3 0.1 µM 0.5-5
mM
1 and 4 [22]
ProX A. fulgidus glycine betaine,
proline betaine
Y Y 1.8 50 nM 1 mM 1 [23]
PotD T. pallidum spermidine - Y 1.8 10 nM n.n 2 [24]
SiaP H. influenzae sialic acid Y Y 1.7 58 nM 5 mM 1 [25]
UehA S. pomeroyi ectoine - Y 2.9 1.1 µM 10
mM
1 [26]
ChoX S. meliloti choline Y Y 1.8 2.7 µM 2 mM 1 and 3 [14,
15]
Table 1. Solved structures of selected SBPs. Listed are the proteins, the host organism, the substrate, whether the
structure was solved in the unliganded-open and/or liganded-closed state, the highest resolution, the biochemically
determined affinity, the used substrate concentration during crystallization and the method used: 1) co-crystallization
2) soaking 3) seeding 4) endogenously bound substrates.
2.2.1. Co-crystallization to obtain the ligand bound structure
The method of co-crystallization ensures the presence of only the substrate bound confor‐
mation of the SBP in solution. One major advantage of co-crystallization is the possibility to
add different ligands into the crystallization trial. A prominent SBP member where several
crystal structures were solved is the maltose binding protein (MBP). This protein binds a
maltose molecule and delivers it to its cognate ABC transporter, which imports maltose into
the cell for nutrient purposes. Substrate ranges from maltose, maltotriose, beta-cyclodextrin
and many other sugar derivatives. All these structures were solved by using the addition of
the substrates to the protein. Another example is the ectoine binding EhuB protein of S. meli‐
loti [27]. Here, the structure was solved with both ligands, ectoine and hydroxyectoine,
which yielded two high-resolution structures. The different binding modes of the substrates
could be detected and the difference in affinity explained. The latter example was only crys‐
tallized in the closed-liganded state and no crystals could be obtained when the crystalliza‐
tion solution was depleted of substrate. This highlights the flexibility of the SBPs and the
presence of multiple conformations of the SBPs in solution and in presence of the ligand. In
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many cases the ligand-closed conformation was crystallized under conditions, which differ
greatly from the unliganded-open conformation also indicating the flexibility in the protein.
2.2.2. Ligand soaking to obtain the ligand bound state
The second method, which can be used to obtain a ligand bound protein structure, is ligand
soaking. Soaking crystals with ligands is often the method of choice to obtain crystals of
protein-ligand complexes owing to the ease of the method. However, there are several fac‐
tors to consider. The crystals may be fragile and soaking in a stabilization buffer or cross-
linking may be required. The soaking time and inhibitor concentration need to be
optimized, as many protein crystals are sensitive to the solvents used to dissolve the ligands.
Although for other proteins ligand soaking is successfully applied, for SBPs this method is
not very commonly used as reflected by the low number of structures solved using this
method. This is likely due to the fact that upon substrate binding the two domains undergo
a relative large conformational change. Since crystal contacts are fragile and are disrupted
easily, large conformational changes induced by soaking can damage crystal contacts result‐
ing either in a massive drop in the resolution of the diffraction or the crystals crack/dissolve
completely.
2.2.3. Seeding – A method to obtain the ligand bound state with unusual substrates
In some cases the ligand used for crystallization cannot be crystallized in a closed conforma‐
tion. This occurs for example when the ligand is not stable during the time of crystallization.
One such example is acetylcholine. During crystallization of the choline binding protein
ChoX from S. meliloti, it became evident that besides the natural ligand choline also actyl‐
choline is bound by this SBP [8]. To understand the binding properties of ChoX, a structure
determination of ChoX in complex with acetylcholine was undertaken. For this purpose the
protein was subjected to co-crystallization experiments. Acetylcholine presents a chemical
compound, which is easily susceptible to hydrolysis especially at non-neutral pH values. Al‐
though the crystallization of ChoX was done at low pH values, a co-crystallization with in‐
tact acetylcholine was achieved. However, subsequent structural determination showed that
the substrate was hydrolyzed to choline in the setup during the time of crystal growth. To
overcome this limitation, a micro seeding strategy was devised. The application of micro
seeding helped to crystallize ChoX complexed with acetylcholine within 24 hours. Structural
analysis revealed that acetylcholine was not hydrolyzed in the drop during this short period
of time required for crystal growth. Thereby, it was possible to solve the structure of ChoX
in complex with acetylcholine. The quality of the crystals was good, resulting in diffraction
up to 1.8 Å [28]. However, one drawback encountered, when crystals of ChoX were ob‐
tained by seeding, was that they all showed a high twinning fraction (up to 50 %). This effect
is possibly due to the rapid growth process where crystals reach their final size within a day
allowing the formation of merohedral twins, a phenomenon one has to take into account
when using the streak seeding method.
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2.2.4. Endogenously bound ligands
During purification of some proteins with high affinity for their substrate often the ligand is
co-purified. Here, OppA from L. lactis is an excellent example. OppA belongs to peptide
binding subgroup of the family of SBPs and is involved in nutrient uptake in prokaryotes
and binds peptides of lengths from 4 to at least 35 residues and with no obvious specificity
for a certain peptide sequence. These peptides bind so tightly that they remain associated
with the protein throughout purification. The crystallization of the closed-ligand state there‐
for is relatively easy since the protein will stay only in the closed-liganded conformation.
This results in a liganded bound structure. To obtain more different states of the protein one
has to remove the ligand first, and afterwards add the wanted substrate. In the case of Op‐
pA the peptide was removed prior to crystallization and incubated either with a different
ligand or no ligand to obtain a ligand free structure. In the case of OppA, the endogenous
peptides can be removed from the protein only by partly unfolding using guanidium chlor‐
ide, which generates ligand-free OppA. This removal of endogenous peptides was required
to allow the binding of defined peptides which was used for crystallization. By this tour de
force Bertnsson et al. were able to solve several structures with different ligands bound as
well as a ligand free structure, explaining the substrate binding specificity of this protein in
great detail [22].
2.3. Crystallization of the closed-unliganded state (state III)
The intermediate states of SBPs have been crystallized as well, although only a couple of
structures have been reported. This energetically unfavorable state has been crystallized not
on purpose in most cases. The choline binding protein ChoX from S. melioti has been crystal‐
lized in the absence of a ligand via micro seeding to gain structural insights into the open,
ligand-free form of this binding protein. These attempts were not successful. Instead, the ob‐
tained crystals revealed a closed but ligand-free form of the ChoX protein. Nevertheless
many structures are known of substrate binding proteins in either their unliganded-open or
liganded-closed states [15].
2.4. Crystallization of a semi-open or semi-closed state (state IV)
During our efforts to solve the crystal structure of the choline-binding protein ChoX from S.
meliloti we used the technique of micro seeding [15] to obtain ChoX crystals in the ligand-
free form. To our surprise, a ligand-free structure, which was different from those that were
expected for the ligand-free closed and/or open forms of SBPs described so far, was ob‐
tained. Here, ChoX was present in a ligand-free form whose overall fold was identical to the
closed-unliganded structure. This structure however, represented a more open state of the
substrate binding protein, which had not been observed before. From the crystal parameters
such as the dimensions of the unit cell is was already obvious that the conformation of the
protein had changed, since one axis of the unit cell appeared to be significantly larger (35 Å)
when compared to the unliganded-closed crystal form of ChoX.
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The structure revealed that the domain closure upon substrate binding does not occur in
one step. Rather, a small subdomain in one of the two lobes is laid open and closes only after
the substrate is bound. This observation was in line with data observed for the maltose im‐
porter system MalFEGK. Here it was observed that the ATPase activity of the ABC trans‐
porter was not stimulated by the maltose substrate binding protein when it was added in
the unliganded-closed conformation. This is likely due to the fact that the subdomain is not
fully closed and rotated outward, which does not activate the transporter. Thus, this bio‐
chemical phenomenon could only be explained by the semi-open/semi-closed structure of
ChoX [14].
2.5. State I-IV: What do they tell about conformational changes
Substrate binding proteins are flexible proteins, which consist of two domains, which con‐
stantly fluctuate between several states of which the open and fully closed state are the most
populated ones. Both domains together build up a deep cleft, which harbors the substrate-
binding site. As described above the structural work on these proteins has been successful
and in the next part a general outcome will be given of what these different states actually
tell us about function and mode of action of this protein family.
The unliganded substrate binding proteins are thought to fluctuate between the open and
closed state. The angle of opening varies between 26° up to 70° as observed in several open-
unliganded structures, suggesting that the extent of opening is likely influenced by crystal
packing. This has been observed very nicely for the ribose binding protein of which three
different crystal structures have been described. Here the opening of the two domains varies
between 43° and 63°. This suggests that the opening can be described as a pure hinge mo‐
tion. The variation of the degree of opening has been elucidated by NMR in solution for the
maltose binding protein MalF. Here 95 % of the protein adopts an open conformation fluctu‐
ating around one state with different degrees of opening.
2.5.1. Open and closed - An overall structure view
As an example for the closing movement observed when comparing the open-unliganded
and closed-liganded structure the glycine betaine (GB) binding protein ProX from A. fulgidus
is highlighted in more detail. ProX has been crystallized in different conformations: a li‐
ganded-closed conformation in complex either with GB or PB (proline betaine) as well as in
an unliganded-open conformation [23]. From the crystallographic parameters it was already
anticipated that crystals differ in the conformation of the protein. ProX crystals were grown
using the vapor diffusion method. The authors attained four different crystal forms de‐
pending on the presence or absence of the ligand (hint 1). Liganded ProX crystallized in
hanging drops using a reservoir solution containing 0.2 M ZnAc2, 0.1 M sodium cacodylate,
pH 6.0-6.5, 10-12 % (w/v) PEG 4000 and they belonged to the space group P21 (crystal form
I). In a different setup, liganded ProX crystallized in sitting drops equilibrated against a res‐
ervoir containing 30 % (w/v) PEG 1500 and belong to the space group P43212 (crystal form
II). Unliganded ProX crystallized in hanging drops against a reservoir solution containing
0.3 M MgCl2, 0.1 M Tris, pH 7.0-9.0, 35 % (w/v) PEG 4000. The first crystals appeared after
Proteins and Their Ligands: Their Importance and How to Crystallize Them
http://dx.doi.org/10.5772/53951
11
2-3 months, and belong to space group C2 (crystal form III). Again using a different setup,
unliganded ProX crystallized in hanging drops equilibrated against a reservoir containing
0.1 M ZnAc2, 0.1 M MES, pH 6.5, 25-30 % (v/v) ethylene glycol. These crystals grew within 4
weeks, reached a final size of 200 × 150 × 20 μm3, and belong to space group P212121 (crystal
form IV) [23]. Thus, the different crystallization conditions as well as space group already
suggested that several different conformations had been crystallized. Initial phases were ob‐
tained by two-wavelength anomalous dispersion of ProX-PB crystals of form IV. All other
structures were determined by molecular replacement.
In Figure 2 the opening and closing of the glycine betaine binding protein ProX from A. ful‐
gidus is highlighted. Here domain II was taken as an anchor point.
Figure 2. Equilibrium between the open and closed states of substrate binding proteins (ProX from A. fulgidus). The
unliganded structure (highlighted in green) of an SBP is fluctuating between the open and closed state (highlighted in
orange). In the absence of substrate this equilibrium is pointing towards the open conformation. In the presence of
the substrate this equilibrium is changed towards the closed conformation. Here the two domains are close together
and side chains of both domains bury the substrate in a deep cleft in between them. (PDB entries: 1SW2, 1SW5). All
Figures containing structures were prepared with pymol (“www.pymol.org”).
Figure 2 highlights the open conformation (green), which is in equilibrium with the closed
state although only a small percentage will be present in the closed unliganded state. Upon
the addition of glycine betaine a stable closed conformation is reached and the equilibrium
is shifted towards this state. Besides the crystal structure of the substrate bound state with
glycine betaine, proline betaine and betaine as a substrate also the open conformation was
crystallized. This allowed a detailed analysis of the closing and opening motion mediated by
the hinge region between both domains. The comparison of the ligand-free and liganded
conformation of other binding proteins showed an approximate rigid body motion of the
two domains highlighting a total rotation of domain II by ~ 58° with respect to domain I
(Figure 2). The total rotation has two components: 1) the hinge angle between the two do‐
mains of ~ 40° with its axis going through the above-mentioned hinges in the polypeptide
and 2) a rotation perpendicular to the hinge axis of ~ 42°. Although the domains behave
more or less as rigid bodies, there are a few changes of the binary complex in two regions of
ProX. If one succeeds in crystallizing several conformation of a protein one can search for
and visualize small distinct changes in the overall structure. This has been also observed in
ProX, the α-helical conformation (in the open form) of residues 144–148 (domain I) change
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either to an isolated-β-bridge or to a turn conformation (in the closed form). This conforma‐
tional change may be caused by the proximity to Arg149, which plays an important role in
ligand binding as discussed below. Furthermore, residues 222–225 (domain II), which are in
turn and 310-helix conformation (in the open form), become rearranged to a short α-helix in
the closed form. These structural changes highlight an important point in the function of
such a protein (more detail below).
2.5.2. Open and closed - An active site view
A closer look at the binding site or the amino acids involved in substrate binding shows that
small but distinct conformational changes of the amino acids involved in ligand binding oc‐
cur upon substrate binding. Again as an example the glycine-betaine binding protein ProX
from A. fulgidus is used.
The binding site is located in the cleft between domains I and II and can be subdivided into
two parts, one binding the quaternary ammonium head group and the other binding the
carboxylic tail of these compounds. The quaternary ammonium head group is captured in a
box formed by Asp109 and the four tyrosine residues Tyr63, Tyr111, Tyr190, and Tyr214 be‐
ing oriented almost perpendicular to each other. The tyrosine side chains provide a negative
surface potential that is complementary to the cationic quaternary ammonium head group
of GB. The carboxylic tail of GB is pointing outward of this partially negatively charged en‐
vironment forming interactions with Lys13 (domain I), Arg149 (domain II), and Thr66 (do‐
main I), respectively. Furthermore the structure was solved at a resolution sufficient to
locate water molecules. An important water molecule was observed, which was held in
place by residues Tyr111 and Glu145, and stabilizes domain closure. Here it is important to
mention that this water molecule was not observed in the open unliganded structure and its
importance would therefore be easily overlooked when no comparison between the two
states were possible.
The superposition of the open-unliganded form and the closed-liganded form of ProX al‐
lowed an unambiguous identification of residues of domain II that are involved in ligand
binding. They show virtually the same orientation in the open and closed forms (see Figure
3). Residues Tyr63, Tyr214, Lys13, and Thr66 superimpose very well. Only the main chain
carbonyl of Asp109 from domain I is slightly out of place compared to the closed form be‐
cause of the enormous main chain rearrangement between Asp110 and Tyr111 upon domain
closure. The residues contributed by domain II behave quite differently. Tyr111 and Tyr190
are not only moved as parts of domain B but they undergo a major conformational change
to adopt the conformation of the closed-liganded binding site. The side chain conformation
of Arg149 shows only small changes between the open and closed conformations although it
undergoes a large movement as part of domain II.
Recently, another structure of ProX was solved in the liganded but open conformation [29].
This conformation represents a state of which only very few structures are known. In other
words, the protein has a ligand bound and is on its way to close up the binding site. This
structure provided an even more detailed picture on the function of ProX and finally high‐
lighted the crucial role of Arg149. In addition to the direct interaction with GB and residues
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that are part of the substrate-binding pocket (Tyr111, Thr66), Arg149 is a major determinant
in domain-domain interactions in the closed structure. As such, Arg149 interacts with Val70
(domain I) and Asp151 (domain II), thereby acting as a linking element between the two do‐
mains enforcing stable domain closure. These interactions complement those mediated by
Pro172 of domain II, where Pro172 interacts via its Cα-atom and a water molecule with
Glu155 of domain II. Together, this provides a further explanation for the crucial role of
Arg149 for the stability of the liganded-closed state, which has been observed in mutagenis
studies. Here, the binding affinity of GB was dramatically lowered when Arg149 was mu‐
tated to alanine, a phenomenon that could not be explained since the aromatic cage which
dominates the binding affinity was still present to bind glycine betaine. This suggested that
Arg149 is the final amino acid to interact with the substrate and, thereby, terminate the mo‐
lecular motions that result in the high affinity closed state of ProX. Besides this crucial role
of switching from a low affinity to a high affinity state via the interaction of Arg149 the open
liganded structure also shed light on the movement that the amino acids undergo during
closure of the protein. In the open-liganded structure the presence of glycine betaine is com‐
municated to Arg149 through interactions of the side chains of Tyr190, Tyr111, and Phe146
via a side-chain network [29]. Interestingly when comparing the open and closed structures
of other SBPs, the maltose binding protein (MBP) [9] and the ribose binding protein (RBP)
from E. coli and the N-Acetyl-5-neuraminic acid binding protein (SIAP) from H. influenza
[25] a similar network can be identified in these proteins, something which had not been
identified before due to the lack of an open-liganded structure.
In summary, the “Venus fly trap” model describes the opening and closing of SBPs. Here
the equilibrium between these two conformations is shifted towards the closed state upon
substrate binding. Many crystal structures of SBPs have been solved in the unliganded-
open, liganded-closed, and, more rarely, in the liganded-open or unliganded-closed state [3,
14, 15, 23]. The crystal structure of one of these states will give information on the overall
structure of the protein as well as the ligand binding site. Several SBPs have been crystal‐
lized in two or more states and quite clearly the increasing amount of states will shed a
more detailed look on how domain closure is occurring. Thus, although crystallization is tri‐
al and error and sometimes tedious, it is worth to search for crystals in the liganded-closed
Figure 3. The binding site of ProX is highlighted in the open (depicted in ball and stick in green-left picture) and the
substrate bound closed conformation (depicted in ball and stick in orange middle picture). As observed some of the
ligand binding amino acid change their conformation. The right picture shows an overlay of both structures to visual‐
ize these conformation changes (PDB entries: 1SW2, 1SW5 and 3MAM).
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conformation as well as crystals of another state since every stage will visualize the clever‐
ness of nature to use conformational changes for the formation of ligand binding sites.
3. Protein with multiple ligands – How to crystallize the different ligand
bound intermediate states
Besides proteins that bind one substrate, a large number of enzymes are binding two or more
substrates and convert these into a product. Here, the crystallization of the apo-enzyme (pro‐
tein without any ligand bound) often reveals the binding site of these ligands. However, the ex‐
act influence of the binding of these ligands can only be deduced from several structures,
where different ligands are bound or one structure with all ligands bound. The different states
are called apo-enzyme, when the enzyme is depleted of all ligands, the binary complex when
the first substrate is bound, the ternary complex when the second ligand is bound as well. A
quaternary complex would describe the protein with three ligands bound.
Figure 4. Overview of the conformations a protein can adopt with multiple ligands. A) The apo-enzyme B) binary
complex where the first ligand is bound. This ligand with the highest affinity induces a stable conformation of the
enzyme which allows the binding of the second ligand (ternary complex CI or CII). D) Enzyme complex where all li‐
gands are bound.
Most of these proteins are enzymes. In reactions mediated by enzymes, the molecules at the
beginning of the process, called substrates, are converted into different molecules, called
products. Almost all chemical reactions in a biological cell need enzymes in order to occur at
rates sufficient for life. Since enzymes are selective for their substrates and speed up only a
few reactions from among many possibilities, the set of enzymes synthesized in a cell deter‐
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mines which metabolic pathways are utilized. Obtaining a snapshot of the substrate bound
enzyme is difficult, because the enzymatic reaction will proceed immediately after substrate
binding. One “trick” mostly used to solve this problem is to inhibit the reaction by either the
reaction condition, meaning by varying pH of the buffer to a value where the reaction is not
occurring. Another approach often appied in crystallography is to use a mutant, which can‐
not catalyze the reaction anymore; however it is still capable of binding the substrate. This
has been proven to be successful in many cases. For example the catalytic cycle of nucleotide
binding domains has been unraveled by such a mutation. In the latter case the ATP hydroly‐
sis, in the wild type the measure for activity, has been abolished by mutation of a crucial
amino acid, which still allowed binding of ATP but prevented hydrolysis. Thereby the di‐
meric state of the protein was stabilized and the active form of the NBD (nucleotide binding
domain) could be crystallized in the presence of ATP [30-32].
Below the structural studies of the octopine dehydrogenases (OcDH) from P. maximus will
be described in more detail. This enzyme catalyses the reductive condensation of L-arginine
with pyruvate forming octopine under the simultaneous oxidation of NADH (reduced form
of nicotinamide adenine dinucleotide). This oxidation of NADH is the terminal step in the
anaerobiosis, meaning the generation of ATP when organisms are suffering from low oxy‐
gen levels. A prominent member of these terminal pyruvate oxidoreductases is the lactate
dehydrogenase, which catalyzes the transfer of a hydride ion from NADH to pyruvate, with
produces NAD+ (nicotinamide adenine dinucleotide) and lactate. Thereby the redox state in
vertebrates is maintained during functional anaerobiosis. OcDH fulfills the same function in
the invertebrate P. maximus.
This enzyme has been chosen due to the fact that three substrates need to be bound simulta‐
neously for the reaction, in contrast to the lactate dehydrogenase, which has only two sub‐
trates, NADH and pyruvate. Furthermore this enzyme was crystallized as wildtype protein
and in all substrate bound states (binary and ternary complex CI and CII) and the corre‐
sponding structures were elucidated. The state where all substrates were present did not
yield a structure due to the immediate conversion to the product. However, the other struc‐
ture allowed a detailed view on how the latter state might look like.
In 2007 Mueller and co-workers achieved cloning and heterologously expression of this en‐
zyme using E. coli as expression system [33]. After the purification the enzyme was charac‐
terized and the authors proposed a sequential binding mode of the substrates. Here, NADH
was bound first followed by either L-arginine or pyruvate. The order of the last two was not
revealed by the enzymatic analysis. Furthermore, a catalytic triad was proposed consisting
of three highly conserved amino acid, building up a protein rely-system for the reduction of
NADH. This triad has been observed in the sequence and structure of the lactate dehydro‐
genase as well. Sequence analysis of different proteins from this family revealed that the
protein contained two distinct domains where domain I contained the characteristic Ross‐
mann-fold, a domain responsible for the binding of NADH. Domain II was assigned as octo‐
pine dehydrogenase domain, which is specific for this protein family and was suggested to
contain the binding site for both L-arginine and pyruvate. Both domains are connected via a
linker region of 5-8 amino acids suggesting that these domains might undergo large confor‐
mational changes.
Advanced Topics on Crystal Growth16
3.1. The crystallization of apo-enzyme and the binary complex
Parallel to the biochemical characterization, the crystallization of the enzyme was started.
Due to the two-domain structure OcDH can adopt multiple conformations in solution,
which prevents crystal formation. However, purified OcDH-His5 yielded small crystals that
appeared to be multiple on optical examinations (Figure 5 A). They diffracted to a resolution
of 2.6 Å. However the diffraction showed multiple lattices in one diffraction image and
could not be used for structure determination (Figure 5 A) [34]. All attempts to improve
these crystals using for example seeding, temperature ramping or various crystallization
conditions failed. Finally, the primary ligand, NADH, was added prior to crystallization.
This produced crystals under conditions similar to those in the absence of NADH. Here, the
incubation temperature appeared to be critical and needs to be kept at 285 K. The crystals
obtained were single and diffracted to 2.1 Å resolution, which allowed processing of the da‐
ta and subsequent structure determination (Figure 5 B). The structure of OcDH was solved
as binary complex with NADH [34, 35].
Cofactors like NADH are often observed to be co-purified. This was assumed to be the case
for OcDH as well, however, no activity was ever observed without NADH, but in the pres‐
ence of the other two substrates. This implies that OcDH is not homogenous and multiple
conformations exist as observed in the multiple crystal lattices of the diffraction image. This
is in line with the only other available three-dimensional structure of an enzyme of the
OcDH superfamily, the apo-form of N-(1-D-carboxylethyl)-L-norvaline dehydrogenase
(CENDH) from Arthrobacter sp. strain 1C [36]. CENDH catalyzes the NADH-dependent re‐
ductive condensation of hydrophobic L-amino acids such as L-methionine, L-isoleucine, L-
valine, L-phenylalanine or L-leucine with α-keto acids such as pyruvate, glyoxylate, α-
ketobutyrate or oxaloacetate with (D, L) specificity [37]. The structure of the binary complex
of CENDH with NAD+ was determined to a resolution of 2.6 Å. Although NAD+ was added
in the crystallization trials the cofactor could not be observed unambiguously in the electron
density. This was likely due to the concentration of NAD+, which was below the Kd. As a
result not all proteins had the substrate bound, which led to a not very well defnied electron
density. Only the nicotinamide ribose moiety was of moderate quality and the density of the
nicotinamide ring was very weak. This has been attributed to low NAD+ occupancy in this
crystal, hence the co-factor has been omitted from the high resolution refinement [36].
This highlights the importance to verify the affinity of substrate prior to crystallization.
Since NAD+ is the product of the reaction and to ensure the release of the product, the affini‐
ty of NAD+ must be lower than the affinity of NADH. In a recent study on the OcDH the
affinities have been determined to be 18 μM for NADH and 200 μM for NAD+ [38]. As de‐
scribed above the addition of substrate in crystallization trials need to be at least a 10-fold
above the Kd. For OcDH 0.8 mM NADH was used for the crystallization of the binary com‐
plex, which represents a 40-fold excess.
The structure of the OcDH-NADH binary complex revealed why the initial crystallization at‐
tempt of the apo-enzyme failed. NADH is bound by the Rossmann-fold located in domain I as
well as by an arginine residue in domain II. Thereby the OcDH captured in a state which ena‐
bles the binding of the other substrates, pyruvate and L-arginine (see below) [34, 35].
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Figure 5. Crystallization of OcDH in the absence and presence of NADH. A) Absence of NADH. The crystals obtained
are multiple (upper panel) and the diffraction pattern yielded showed several lattices (middle panel). The structure of
OcDH shows two distinct domains connected by a flexible linker, which can rotate freely in the absence of NADH (low‐
er panel). B) Crystals obtained in the presence of NADH (upper panel). The diffraction showed a single lattice diffract‐
ing up to 2.1 Å (middle panel). The structure revealed the binding site of NADH and an interaction of an arginine
residue from domain II with NADH, which locks OcDH in one stable conformation (lower panel) (PDB entries: 3C7A
and 3C7D).
In summary, the apo-state of multiple ligand binding enzymes is difficult to crystallize
when the enzyme undergoes large conformational changes. In the case of the OcDH only the
binary complex in the presence of NADH could be crystallized. Here crystals were of suffi‐
cient quality to determine the structure.
Advanced Topics on Crystal Growth18
3.2. The crystallization of the ternary complexes CI and CII
OcDH catalyzes the condensation of L-arginine with pyruvate to form octopine under the
oxidation of NADH. Biochemical analysis as well as the crystal structure revealed that
NADH is the first substrate to bind to OcDH. The structure of this binary complex exhibit‐
ed a stable conformation of the protein in solution with an Arg-sensor, which binds NADH,
and thereby stabilizes the protein in one conformation (see above).
So the next step was to determine the structure of the OcDH in the presence of the second
and third substrate, L-arginine and pyruvate, respectively. Initially, the protein and the sub‐
strate were mixed and an extensive search for suitable crystallization conditions was started.
However, no crystals were obtained for OcDH in the presence of L-arginine and/or pyru‐
vate. Instead only needles were grown which were multiple and very fragile similar to the
crystals obtained for the apo-enzyme. This is in line with the biochemical data, which high‐
lights the order of substate binding which show that NADH has to be bound prior to bind‐
ing of L-arginine as well as pyruvate [38, 39]. Here the authors used two other techniques,
NMR and ITC (isothermal titration calorimetry) repectively, to show that L-arginine only
binds after saturation of the apo-enzyme with NADH. Pyruvate was shown to be bound on‐
ly after L-arginine binding to the enzyme. This suggests that OcDH undergoes a conforma‐
tional change when NADH is bound and thereby the binding site of L-arginine is formed.
Furthermore the binding site for pyruvate is only created when L-arginine is bound.
Since crystallization was not successful the next step was to use co-crystallization with the
OcDH protein and L-arginine and/or pyruvate to obtain structural information of the terna‐
ry complex (CI and CII). This yielded crystals of OcDH only in the presence of NADH and
no additional density was observed for neither L-arginine nor pyruvate. So, soaking the li‐
gand into preformed OcDH-NADH crystals was the last method chosen. Crystallization tri‐
als were carried out using the hanging-drop vapor diffusion method and crystals of OcDH
were grown in the presence of 0.8 mM NADH. L-arginine-bound crystals were obtained by
soaking NADH-bound OcDH crystals in 100 mM MES pH 7.0, 1.15 M Na-citrate, 0.8 mM
NADH containing 10 mM L-arginine for at least 24 hours. Pyruvate-bound crystals were ob‐
tained also by soaking the crystals in 100 mM MES pH 7.0, 1.15 M Na-citrate, 0.8 mM
NADH and 10 mM pyruvate for at least 8 hours. Both concentrations were chosen relatively
high but they resemble the in vivo concentration as well as were backed up by the affinity
observed for both substrates in biochemical and biophysical studies, being 5.5 mM L-argi‐
nine and 3.5 mM pyruvate, respectively. During soaking a cracking of the crystals was ob‐
served after the first minutes. However, the crystals recovered completely from this cracking
within the following hours and showed no fissures or other damages after that soaking pro‐
cedure. Desprite this, the diffraction analysis revealed a loss in diffraction. Initally the crys‐
tals diffracted to 2.1 Å. After soaking in L-arginine or pyruvate the diffraction potential was
reduced to 3.0 Å and 2.6 Å, respectively. The phenomenon of crystal cracking and decline of
the diffraction already was a good indication that the substrates diffused into the crystal. A
dataset was collected from crystals where either one of the ligands was soaked in and be‐
sides the decrease in diffraction potential also the unit cell parameters changed (see Table 2).
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Crystal Complex Unit cell parameters ( a,b,c in Å)
OcDH-NADH 99.8, 99.8, 126.5
OcDH-NADH/L-arginine 95.9, 95.9, 117.9
OcDH-NADH/pyruvate 95.0, 95.0, 120.2
Table 2. Crystallographic parameters of the unit cell of the binary OcDH-NADH complex and after soaking of the
ternary complex CI: OcDH-NADH/L-arginine and CII: OcDH- NADH/pyruvate
The change in unit cell parameters suggested that a conformational change occurred during
the soaking with the ligand. This was further observed after the structure was resolved and
electron density was clearly defined for L-arginine in the one and for pyruvate in the other
dataset. The structure of OcDH-NADH/L-arginine showed a rotational movement of do‐
main II towards the NADH binding domain I, and a stronger interaction of the Arginine res‐
idue with NADH. A domain closure was also observed in the pyruvate bound structure. So
stable binding of NADH to the Rossman fold of domain I, the first step in the reaction se‐
quence of OcDH, occurs without participation of domain II. A comparison of the OcDH-
NADH (colored light-purple in Figure 6) and the OcDH-NADH/L-arginine complexes
revealed a 42° rotation of domain II towards the NADH binding domain (domain I) in the
latter complex. This domain closure is triggered by the interaction of Arg324 (domain II)
with the pyrophosphate moiety of NADH bound to the Rossman fold in domain I.
A comparison of the two ternary complexes suggests that both, pyruvate and L-arginine, are
capable to trigger domain closure to a similar extent. However, in the OcDH-NADH/pyruvate
complex, pyruvate partially blocks the entrance for L-arginine, while in the OcDH-NADH/L-
arginine complex, the accessibility of the pyruvate binding site is not restricted by L-arginine
[34, 35]. From these structures it could be deduced that L-arginine binds to the OcDH-NADH
complex in a consecutive step and induces a rotational movement of domain II towards do‐
main I. This semi-closed active center, which is further stabilized using the pyrophosphate
moiety of the bound NADH and by interactions of L-arginine with residues from both do‐
mains is then poised to accept pyruvate and consequently the product octopine can be formed.
With regard to the structures it was proposed that instead of a random binding process, an or‐
dered sequence of substrate binding in the line of NADH, L-arginine and pyruvate will occur.
This ordered sequence of substrate binding was then biochemically proven by ITC studies
where the binding affinities of the substrates were measured. Here, the binding of L-argi‐
nine was only observed when NADH was bound primarily and the binding of pyruvate on‐
ly when the complex was preloaded with L-arginine [38, 39]. Furthermore this ordered
binding mechanism explains why no lactate is found in side P. maximus which is normally
formed when NADH and pyruvate is bound by lactate dehydrogenases. Here, it is worth
mentioning that the conformational changes induced by ligand soaking into the crystal
were also observed in NMR studies that were perfomed in solution. So the apparent confor‐
mational changes in the crystal resemble the changes the protein undergoes in solution.
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Figure 6. Overlay of the OcDH-NADH binary complex with the OcDH-NADH/L-arginine ternary complex CI. As seen in
the superposition the binding of L-arginine induces a conformational change. Domain II is rotated towards domain I
which is thereby creating the pyruvate binding site. In the overlay the pyruvate structure is not shown due to clarity
(PDB entries: 3C7A and 3C7D).
The crystal structures of the different states of OcDH, delivered snapshots elucidating for
the first time the precise and very distinct binding order [35]. Unfortunally the crystals with
the endproduct octopine did not diffract X-ray with a resolution and quality high enough
for structure determination. The same hold true for a complex with all three substrates
present at once. This is likely due to the fact that the immediate condensation occured and
the product was formed.
To show how proteins can be crystallized with their enzymatic endproducts we chose an‐
other enzyme family as example and will describe the different procedures during the next
paragraphs.
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4. Enzymatic products in protein structures – How to crystallize this
rather unfavored states
The state found to be important within an enzyme reaction cycle is supposedly the product
bound state. After the reaction occurs the product is still sitting within the protein and will
be released. Often these product have a low(er) affinity to the protein than the substrates
and are therefor less often found to be successfully crystallized.
Examples of prosperous structure determination however are the shikimate dehydrogenase
(SDH or AroE) of Thermus thermophilus (TthSDH), Aquifex aeolicus (AaeSDH) and the recently
deposited structures of the SDH of Helicobacter pylori (HpySDH) as well as the bifunctional
dehydroquinase-shikimate dehydrogenase (AthDHQ-SDH) from Arabidopis thaliana which
were crystallized with its reaction product shikimic acid ([40-43]. Similar to that the closely
related quinate dehydrogenase (QDH) of Corynebacterium glutamicum (CglQDH) was struc‐
turally characterized in four different states: as apo-enzyme and at atomic resolution with
bound cofactor NAD+ as well as in complex with quinic acid (QA) and the reduced cofactor
or shikimic acid (SA) and NADH [44].
Shikimate-/quinate dehydrogenases belong to the superfamily of NAD(P)-dependent (nico‐
tinamide adenine dinucleotide phosphate) oxidoreductases whereas SDHs catalyse the re‐
versible reduction of 3-dehydroshikimate to shikimate under oxidation of NAD(P)H
(reduced form of nicotinamide adenine dinucleotide phosphate) and QDHs the oxidation of
quinate to 5-dehydroquinate with reduction of NAD(P), respectively. The overall fold con‐
sists of a N-terminal or substrate binding domain and a C-terminal or cofactor-binding do‐
main and is highly conserved within that subfamily (schematically shown in Figure 7).
Compared to other proteins, like the above-mentioned SBPs, the structural changes occur‐
ring during catalysis are less prominent and comprise a movement of the two domains
against each other in a range of several Ångstrom.
4.1. Shikimate dehydrogenase from Aquifex aeolicus
Crystals of the native (apo-) AaeSDH were obtained with non-His-tagged protein, whereas
the ternary complex crystals were obtained with His-tagged SDH. To get these complexes
the protein solution was mixed with substrate and cofactor (i. e. with both natural products)
to final concentrations of 5.0 mM shikimic acid and 5.0 mM NADP+ before crystallization.
The hanging-drop vapor diffusion method was used for crystallization trials. The drops
were prepared by mixing 3 μl of the protein-ligand solution with 1 μl of well solution [41].
KM values were determined to be 42.4 μM for both ligands, which means that there was a
100-fold excess in the crystallization drop. The bound products SA and NADP+ in the pro‐
tein could be explained by the low activity of the enzyme and the equilibrium constant fa‐
voring the formation of SA and NADP+, both of which are caused by the low pH. The
equilibrium constant ([SA][NADP+]/[DHSA][NADPH]) was determined by Yaniv and Gil‐
varg (1955) to be 27.7 at pH 7 and 5.7 at pH 7.8 [45]. As of any dehydrogenase reaction, the
equilibrium position of the AaeSDH-catalysed reaction depends on the hydrogen ion con‐
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centration of the environment. The pH of the well solution (0.2 M ammonium acetate, 30 %
w/v PEG 4000, 0.1 M sodium acetate) was 4.6 and therefore the drop became more acidic
during crystallization. They estimated the equilibrium constant at pH 5 to be around 3000 in
favor of the formation of SA and NADP+. The geometry of NADP+ is not distinguishable
from that of the NADPH at this resolution (2.2 Å) but the geometry of SA containing a tetra‐
hedral (sp3) C3 atom is distinct from that of DHSA, in which the geometry of C3 is planar
(sp2) [41].
There were eight (apo) and four (ternary complex) crystallographically independent
AaeSDH molecules in the asymmetric unit of apo-AaeSDH or AaeSDH-NADP+-SA, respec‐
tively. According to the structure of the apo-protein and the ternary complex a fully open
(molecule F in apo-AaeSDH) and a closed conformation with bound ligands (molecule D in
AaeSDH-NADP+-SA; Figure 8) were observed as well as several intermediate states. From
Figure 7. Schematic diagram of the conformational changes within a protein (blue ellipses) during the catalyzed reac‐
tion. 1.) Before a substrate (red trapezium) is bound the proteins exhibits an open conformation. 2.) – 4.) Binding of
the substrate induces a slight domain closure before the cofactor (green hexagon) is bound. 5.) + 6.) In order to facili‐
tate the conversion from substrate to the product (orange rhombus) both protein domains need to be in close con‐
tact. 7.) -9.) A stepwise domain opening allows the changed cofactor (light green pentagon) to leave the protein
domain, followed by the product. The protein itself is not modified at all during the whole reaction and mostly all
steps are reversible.
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the fully open to the closed form there is a movement of three loops in the catalytic domain
towards the NADP-binding domain by around 5 Å sealing the active site of the enzyme. SA
and NADP+ are brought in close contact in that cavity: the C3-O3 bond of SA is parallel to
the C4-C5 bond of the nicotine amide ring of NADP+, and the distance between the two
bonds is 3.5 Å. This represents a typical distance for a hydride transfer.
The open conformation therefor represents the protein structure in state 9.) (or 1.), respec‐
tively) in Figure 7, the closed conformation correlates to state 6.) in that scheme.
Figure 8. Shikimate dehydrogenase from Aquifex aeolicus. The cartoon depicted in cyan represents the open (apo)
conformation of the enzyme (PDB entry: 2HK8), the structure coloured in black illustrates the closed conformation
(PDB entry: 2hk9) with the bound ligands shikimic acid and NADP+, shown as sticks.
4.2. Shikimate dehydrogenase from Thermus thermophiles
In case of TthSDH, crystals of the native protein were grown in microbatch plates. Co-crys‐
tallization trials were only successful with added NADP+ but failed with shikimate. To ob‐
tain complexes with bound shikimate crystals of the apo-protein or the SDH-NADP+
complex were soaked for several seconds in cryosolution supplemented with shikimate. The
final concentration of all added ligands was 5 mM. Although the kinetical parameters were
not determined prior to crystallization, all KM values of closely related SDHs are in a μM
range so that there was at least a 20-fold excess of substrate and cofactor [40].
Evaluation of the complex structures revealed an open and a closed conformation of the two
domains but neither the binding of shikimate nor NADP+ seem to induce that conformation‐
al change. Shikimate could bind to the closed as well as to the open form, whereas NADP+
was found only in closed conformation. As described for AaeSDH, the crystallization condi‐
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tion was in an acidic range of about pH 4.6, which explains that the reaction did not occur.
An alignment of the three structures (apo-SDH, SDH-SA, SDH-SA-NADP+) of T. thermophi‐
lus illustrates the domain closure while/after SA and/or NADP+ binding (Figure 9). Surpris‐
ingly there seems to be no further movement of the substrate binding domain against the
NADP(H) binding domain when the cofactor is bound. Thus, the apo-structure represents
state 9.) (or 1.) in Figure 7 and both the binary and the ternary complex may match a state
between 6.) and 7.) of that scheme.
Figure 9. Shikimate dehydrogenase from T. thermophilus. The cartoons depicted in green (left and right side) repre‐
sent the open (apo) conformation of the enzyme (PDB entry: 1WXD), the structure coloured in black illustrates the
closed form with bound shikimic acid (PDB entry: 2D5C), whereas the red one corresponds to the ternary complex
(PDB entry: 2EV9) with shikimic acid and NADP+, shown as sticks.
4.3. Bifunctional dehydroquinase-shikimate dehydrogenase (AthDHQ-SDH) from
Arabidopis thaliana
Remarkable are the co-crystallization trials of Singh and Christendat with the bifunctional
enzyme dehydroquinase-shikimate dehydrogenase from Arabidopsis thaliana (AthDHQ-
SDH). First crystals were obtained with the product shikimate at the SDH site and tartrate as
a substrate analogue at the DHQ site. Later they could crystallize AthDHQ-SDH with its
natural products shikimate and NADP+.
For the shikimate-tartrate complex crystals they used the vapor diffusion hanging-drop
technique. Protein solution with a final concentration of 1 mM of shikimate was mixed with
the reservoir solution containing 0.4 M potassium sodium tartrate tetrahydrate [42]. To ob‐
tain ligand bound crystals of the three different protein conditions were tested: protein only,
protein with 1 mM shikimate or protein with 1 mM NADP+. The protein-shikimate ap‐
proach was the only one that yielded crystals (under the same conditions as mentioned
above). To gain crystals of the ternary complex a further treatment was necessary: The
above-mentioned crystals were soaked with a NADP+ solution (final concentration 10 mM)
for about 8 hours at pH 5.8. The KM values were determined to be 0.6 mM for shikimic acid
and 0.13 mM for NADP+, respectively [42].
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Not only that the closed conformation of the enzyme after binding of both products could be
demonstrated (Figure 10) but also the activity of that ternary complex was proven as the oxi‐
dation of shikimate was evidenced by the generation of dehydroshikimate, – the product of
the DHQ moiety – found in the DHQ site [43].
Figure 10. Bifunctional dehydroquinase-shikimate dehydrogenase (AthDHQ-SDH) from Arabidopis thaliana. The car‐
toon coloured in grey reveals the binary complex (PDB entry: 2GPT) with the bound product shikimate (grey lines), the
structure depicted in red shows the protein with bound substrate dehydroshikimate (red lines; PDB entry: 2O7Q),
whereas the cartoon in green represents the ternary complex (PDB entry: 2O7S) with bound dehydroshikimate and
the cofactor NADP(H).
The structures of the AthDHQ-SDH binary complexes with bound product shikimate or
substrate dehydroshikimate illustrate therefore the states 8.) or 2.), while the ternary com‐
plex corresponds to the transition state 5.) in Figure 7.
4.4. Shikimate dehydrogenase from Helicobacter pylori
Recently three different catalytic states of the HpySDH were deposited in the PDB. Unfortu‐
nately the results are not published so that detailed information about the crystallization tri‐
als are lacking. Apparently they obtained all crystals by means of the hanging-drop vapor
diffusion method.
However, the structure is ideally suited to visualize structural changes during cofactor bind‐
ing Figure 11.
In the binary structure of the HpySDH with bound shikimate there is a large loop in the C-
terminal domain that obstructs the entrance to the cofactor-binding cleft and virtually acts
as a lid. For cofactor binding this loop has to move away from the cleft in order to create
space for NADP(H). Comparing these two structures with the overall conformation of the
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apo-protein, these two conformational stages represent stages 2.)/3.) or 6./7.), in the catalytic
cycle shown in Figure 7.
4.5. Quinate dehydrogenase from Corynebacterium glutamicum
Last but not least the bacterial quinate dehydrogenase of C. glutamicum could be structurally
solved in four different catalytic states: apo-enzyme, with bound cofactor NAD+ and in com‐
plex with quinate (QA) and the reduced cofactor or shikimate (SA) and NADH, i. e. with the
natural substrate and the natural cofactor as product of the reaction.
For growing the crystals of the apo-form the protein solution was mixed with the reservoir
solution and a NADH solution (2 μg/ml) in a drop ratio 1:1:1. The reduced cofactor could
not be detected in the electron density due to the very low concentration [46].
For the co-crystallization trials (with the cofactor NAD+, the substrate quinate (QA) and the
reduced cofactor or shikimate (SA) and NADH) the kinetical parameters were determined
first in order to get an idea of the concentrations necessary for successful ligand binding.
The KM values for NAD+, QA and SA are 0.28 mM, 2.37 mM and 53,88 mM, respectively
(Hoeppner et al.; publication in progress).
To obtain the binary  and both of the ternary complexes  the protein solution was mixed
with either NAD+ or QA plus NADH or SA plus NADH to a final concentrations of 1 mM
for NAD+ or NADH and 35 mM for QA or SA. These mixtures were incubated on ice for
about 1 hour prior to crystallization. All  substrates and the cofactor were bound during
co-crystallization experiments by means of the sitting drop method with drop size of 2-4
μl in 1:1 ratio of protein and reservoir solution.
Crystals of the binary and ternary complexes were different in shape compared to the crys‐
tals of the apo-enzyme and grew under diffenrent conditions (Figure 12), which was a hint
to (structural) changes within the protein molecules.
Figure 11. Binary (left; PDB entry: 3PHI) and ternary structure (right; PDB entry: 3PHH) of the shikimate dehydrogen‐
ase from Helicobacter pylori. The substrate dehydroshikimate and the cofactor NADP(H) are presented as sticks. The
red circle indicates the loop region in the N-terminal domain which acts as a lid during cofactor binding.
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The crystals of all three CglQDH complexes diffracted to atomic resolution and allowed us to as‐
sign the position of all ligand atoms unambiguously within the electron density (Figure 13).
Figure 13. Representative sections of electron density maps of the CglQDH complexes at 1.0 Å (CglQDH-NAD+) or 1.16
Å (CglQDH-QA-NADH and CglQDH-SA-NADH) resolution. A) electron density defining protein side chains, B) density
around the nicotinamide ring of the cofactor NAD(H), C) bound substrate quinate, D) bound substrate shikimate (elec‐
tron density maps in A)-C) contoured at 1 σ and in D) 0.7 σ).
Apo CglQDH CglQDH-NAD+ CglQDH-QA-NADH CglQDH-SA-NADH
100 mM sodium acetate pH
4.6, 200 mM NaCl, 20 %(v/v)
2-methyl -2,4-pentanediol
(MPD)
1.6 M sodium citrate tribasic
dihydrate pH 6.9, plus up to
62 mM CoCl 2
24 %(w/v) PEG 6000, 360 to 400 mM CaCl 2, 100 mM
Tris-HCl pH 8.0 to 9.5
Figure 12. Comparison of the crystal shapes of the four different catalytical states of the CglQDH and the correspond‐
ing crystallization conditions.
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By comparing the overall structures of all these states an open, a semi-open and a closed
conformation of the enzyme (Figure 14) was observed. Surprisingly, the apo-structure of the
CglQDH exhibits the closed form although one would intuitively expect the open conforma‐
tion. But it is possible that these findings were a crystallization artifact since the reservoir
solution was quite acidic (pH 4.6) compared to the CglQDH pH optimum, which is 9.0-9.5
for quinate and 10.0-10.5 for shikimate (Hoeppner et al.; publication in progress).
Within the cofactor binding domain of CglQDH the glycine rich loop, which is highly con‐
served within SDH proteins and represents a classical Rossmann fold, is flapped down to‐
wards the cofactor binding cleft in the apo-structure, but moved away when the cofactor is
bound. With regard to the overall arrangement of the apo-state compared to the NAD+-
bound state there is a clearly visible opening of the two domains. After forming the ternary
complex the two domains are brought closer to each other, if only more slightly compared
to the apo-conformation and thus adopt a semi-closed conformation (Hoeppner et al.; publi‐
cation in progress).
Figure 14. Structural alignments of the binary structure of CglQDH with bound NAD+ (black; PDB entry: 3JYO) and A)
the apo-protein (green; PDB entry: 2NLO) or B) the ternary structure with bound quinic acid and NADH (red; PDB en‐
try: 3JYP). The substrate and the cofactor NAD(H) are presented as sticks. The red arrow indicates the conformational
changes within the glycine rich loop.
4.6. Insights into the structural changes during catalysis and elucidation of substrate and
cofactor specificity, using the example of CglQDH
4.6.1. Structure overview of C. glutamicum QDH
All CglQDH structures presented here are determined from crystals that were nearly iso‐
morphous and belong to the same space group C2. The unit-cell parameters are very similar
with one monomer per asymmetric unit.
The 282 residues in the QDH molecule form two structural domains (Figure 15): the N-ter‐
minal or catalytic domain (residues 1 to 113 and 256 to 283), which binds the substrate mole‐
cule, and the C-terminal or nucleotide binding domain (residues 114 to 255). The catalytic
domain forms an open α/β sandwich, which is characteristic for enzymes of the S/QDH fam‐
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ily but different from all other known proteins. The domain consists of a six-stranded, main‐
ly parallel β sheet (strand order β2, β1, β3, β5, β6 and β4, where β5 is antiparallel. This β
sheet is flanked by helices α1 and α11 at one side and α2, one 310-helix and α4 at the other.
The C-terminal domain contains a six-stranded parallel β sheet (strand order β9, β8, β7, β10,
β11 and β12) sandwiched by three helices (α7, α6, α5) on one face and by helices α8, α10
and a 310-helix on the other. The nucleotide binding domain exhibits a glycine rich loop with
the sequence motive GXGGXG. The overall fold of this functional domain is very similar to
that observed for other SDH proteins [47, 48] and represents the classical Rossmann fold.
Both domains are linked together by helices α5 and α11. The arrangement of these two do‐
mains creates a deep active site groove in which cofactor and substrate are located.
Figure 15. Schematical overview of the CglQDH fold
4.6.2. Description and analysis of QDH active site
Cofactor Binding Site: The electron densities for NAD(H) were of high quality and allowed us
to assign the position of these ligand unambiguously at 1.0 Å. CglQDH crystallizes in the
presence of NAD+ in the same space group with similar unit cell dimensions, but under dif‐
ferent crystallization conditions compared to the apo-enzyme. With regard to the overall
structure we found that the catalytic domain moves away from the nucleotide-binding do‐
main after cofactor binding making the interdomain cavity larger. Concerning the steric con‐
figuration of the residues there are only little but fundamental variances, especially in the
glycine rich loop. In comparison to the QDH apo-enzyme (PDB entry 2NLO) the residues of
the loop (Gly136-Val138) move out of the cavity after cofactor binding and therefore clear
space for the NAD(H) molecule (Figure 14). Cofactor binding occurs in an extended groove
between the N-terminal and C-terminal domain, whereas most of the molecular interactions
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result from the C-terminal domain. The adenine part of the adenosine moiety form hydro‐
gen bonds only to some water molecules, while the ribose is bound by the side chains of
Asp158 and Arg163. The phosphate moiety contacts the glycine rich loop and forms hydro‐
gen bonds to Arg163 and the backbone nitrogen atom of Val138. The following ribose moi‐
ety again interacts only with water molecules, whereas the nicotinamide moiety is cramped
by the backbone nitrogen of Ala255 and backbone oxygens of Val228 and Gly251, respec‐
tively. Gly251 and Ala255 are the only residues of the N-terminal domain involved in cofac‐
tor binding (Figure 16). The nucleotide-binding motive GXGGXG comprises the residues
Gly134-Ala135-Gly136-Gly137-Val138-Gly139 (Hoeppner et al.; publication in progress).
Figure 16. Interactions between the cofactor NAD(H) and CglQDH. Residues involved in hydrogen bonds (dotted
lines) and bound ligand are shown as sticks, water molecules are depicted as red stars.
The strict specificity for NAD(H) is determined by the negatively charged aspartate residue
158, the neutral Leu159 and the bulk side chain of Arg163, which would result in steric hin‐
drance with the additional phosphate group in the NADP(H) molecule.
Substrate Binding Site: We examined the substrate binding site of CglQDH by analysis of the
two different ternary complexes QDH-QA-NADH and QDH-SA-NADH. The substrate
binding site is located in the N-terminal domain, close to the nicotinamide ring of the cofac‐
tor, and is characterized by a number of highly conserved residues.
After quinate binding a slight closure of the N- and C-terminal domain of CglQDH so that
the crevice becomes closer by about 0.5 Å was observed. The substrate quinate is  anch‐
ored by numerous key interactions with these residues: the carbonyl group of quinate is
bound by the hydroxyl groups of Ser17 and Thr19; the hydroxyl groups of the C1 and C3
atom of the substrate form hydrogen bonds to side chain of Thr69, whereas the nitrogen
atom of Lys73 binds to the hydroxyl groups of C3 and C4, the latter furthermore interacts
with the side chains of Asn94 and Asp110; the fourth hydroxyl group at C5 forms hydro‐
gen bonds to the amide group of Asp110 and the oxygen atom of the Gln258 side chain,
respectively.  A total  of  eleven hydrogen bonds  cause  a  forcipate  anchorage  of  the  sub‐
strate molecule (Figure 17 B).
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Figure 17. Active site residues of CglQDH. A) Apo-CglQDH (PDB entry: 2NLO) with bound glycerol (purple), B) ternary
complex (PDB entry: 3JYP) with bound quinate (orange), C) ternary complex (PDB entry: 3JYQ) with shikimate (wheat).
Residues involved in hydrogen bonds (dotted lines) and bound ligand are shown as sticks, water molecules are depict‐
ed as red stars.
In comparison to the apo-enzyme QDH (Figure 17 A) it is noteworthy that the side chain of
Lys73 exhibits a sprawled conformation after quinate binding, which is required for interac‐
tion with the C3 and C4 hydroxyl groups of the substrate. For the hydride ion transfer from
C3 of quinate to C4 of NAD+ a particular distance between these atoms is very important. In
the crystal structure the nicotinamide ring is located in a suitable orientation for the H-
transfer. After quinate binding and resulting closure of the domains the cofactor approaches
to the substrate-binding site, whereby the distance of interest amounts to 4.27 Å.
In the case of shikimate binding a somewhat different situation was observed. In principle
the above mentioned residues except Thr19 are involved in shikimate binding (Figure 17 C),
but only eight polar interactions are achieved (compared to eleven when QA is bound),
from which some are furthermore weaker pronounced: Thr19 is not involved in polar con‐
tacts to SA, Thr69 has contact only to the hydrogen group of C3, Asn94 is about 0.2 Å farer
apart from the hydrogen atom of C4 and has no contact to the OH-group of C5. Remarkable
is the appearance of an alternative side chain conformation of Lys73, as evidenced by the
excellent electron density in this region. The first conformation of the Lys73 side chain in the
crystal exhibits the sprawled conformation as found for the quinate binding; the second con‐
formation reveals an angled rotamer as it occurs in apo-CglQDH. The latter conformation
makes hydrophobic interactions with the shikimate molecule impossible (Hoeppner et al.;
publication in progress). Furthermore the shikimate molecule exists in a half-chair confor‐
mation, whereas the quinate molecule adopts a chair conformation. Hence the distance of
the C4 atom of the cofactor and the C3 atom of the substrate increases to 4.67 Å. All residues
involved in cofactor and substrate binding identified here are consistent with these of fur‐
ther reported structures (i. e. TthSDH, AaeSDH, AthDHQ-SDH).
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4.6.3. Substrate and cofactor specificity and discrimination
All results of the structural analysis are also in excellent agreement with the findings of the
kinetical assays. The higher affinity of CglQDH to the substrate quinate (as obvious by
means of the clearly unequal KM values) arises from the major quantity of hydrogen bonds
between protein and the substrate quinate. Considering the known structures of shikimate
dehydrogenases as SDH from T. thermophilus [40] SDH from A. aeolicus [41] or the SDH do‐
main of A. thaliana [42, 43] they all possess at least eleven hydrogen bonds to the substrate
molecule shikimate, comparable to the quinate binding in CglQDH. In contrast there are on‐
ly eight polar interactions present between the enzyme and the shikimate molecule, because
shikimate offers a somewhat different conformation (half-chair instead of chair) and exhibits
no hydroxyl group at the C1 atom. Furthermore the formed hydrogen bonds between shiki‐
mate and the enzyme are accomplished weaker. The higher catalytic efficiency of CglQDH
regarding to quinate (as obvious on the basis of significantly higher kcat/KM values) possibly
results from the slightly lower distance between the C4 atom of the cofactor NAD(H) and
the C3 atom of the quinate molecule (4.27 Å versus 4.67 Å) and the improved orientation of
the substrate quinate.
A further occasion for the lower affinity and catalytic efficiency regarding shikimate results
from the appearance of an alternative conformation of the Lys73 side chain (Figure 17 C),
which leads to a loss of an important hydrogen bond. At last we compared the substrate bind‐
ing residues of CglQDH with those of AaeQDH, AthDHQ-SDH and TthSDH, which convert
shikimate. We detected two differences possibly jointly responsible for quinate binding: in all
the above-mentioned structures a tyrosine residue is involved in shikimate binding but not in
CglQDH (Tyr230). Furthermore the second serine, which forms a hydrogen bond to the car‐
bonyl group of shikimate, is replaced by a threonine residue in CglQDH (Thr19). Since the car‐
bonyl group of shikimate bound in CglQDH is twisted about 90° compared to the situation of
the aforesaid enzymes, Thr19 cannot take part in polar interaction with the substrate shiki‐
mate. Concerning the usage of the cofactors NAD(H) and NADP(H) the classical dinucleotid
fold were identified in the past. Characteristic for all nucleotide binding proteins is the glycine
rich loop with the common sequence GXGXXG, in which the number of glycine residues
changes [49]. Enzymes using NAD or FAD possess a well conserved negatively charged ami‐
no acid at the C-terminus of the second β-strand of the nucleotide binding βαβ unit, mostly as‐
partate or glutamate. This residue interacts with the 2´-hydroxyl group of the ribose. In the
majority of the NADP binding proteins this negatively charged residue is absent since the ad‐
ditional 2´-phosphate group is located at this position. Moreover, various NADP dependent
proteins exhibit a charged amino acid (like arginine) in the position of the 2´-phosphate group
which stabilizes the cofactor molecule. The CglQDH described here offers a negative charged
residue (Asp158) forming a hydrogen bond to 2´-hydroxyl group of the ribose, followed by a
neutral amino acid (Leu159) which is unable to interact with an additional phosphate group as
present in NADP. Furthermore the bulk side chain of Arg163 constrict the cofactor binding
site,  which  would  result  in  steric  hindrance  with  the  additional  phosphate  group  in  a
NADP(H) molecule. Due to all results of the kinetical and structural analysis we conclude that
CglQDH is strictly NAD(H) specific and not able to bound NADP(H).
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5. Conclusions
Crystal structures of proteins and enzymes are important to fully understand the mecha‐
nism and mode of action. Although the crystallization of a large number of proteins was
successful and delivered valuable information the goal must be to fully understand the
function. When crystallizing a protein a snapshot of the protein in a certain conformation is
observed in the electron density. It is known that proteins are flexible and can obtain several
states in solution.
Within that book chapter we explained the importance to acquire structural information of
different catalytical states of proteins or enzymes, to fully understand how the protein be‐
haves during catalysis or how the substrate bound state differs from the apo-enzyme.
The open and closed structures of the substrate binding protein ProX as apo-protein or with
different substrates bound revealed enormous conformational changes during ligand bind‐
ing and clearly visualzes how flexible a protein can be and elucidates the side chain move‐
ments within the substrate site upon ligand binding.
All described crystallization trials of the different transition states of the OcDH showed im‐
pressively that protein crystallization is a trial and error approach and that knowledge of the
protein (especially the kinetical parameters beside others) is the essential thing to be success‐
ful. At best and as recompenses for ones effort one will achieve important insights that clear‐
ly explains the catalytic mechanism.
Last but not least the different structural information of the enzymes of the shikimate dehy‐
drogenase family could bring to light how substrate and cofactor specificity and discrimina‐
tion can be achieved throught detailed analysis of apo-, binary and ternary structure
information about involved amino acids in substrate and cofactor binding.
So with these three examples the difficulties in crystallization on one hand and on the other
hand the beauty of looking at proteins at work is shown.
PDB entries used
Protein PDB Code Title
ChoX 2RF1 Crystal structure of ChoX in an unliganded closed conformation
3HCQ Structural analysis of the choline binding protein ChoX in a semi-closed and ligand-free
conformation
2REJ ABC-transporter choline binding protein in unliganded semi-closed conformation
2RIN ABC-transporter choline binding protein in complex with acetylcholine
2REG ABC-transporter choline binding protein in complex with choline
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Protein PDB Code Title
ProX 1SW1 Crystal structure of ProX from Archeoglobus fulgidus in complex with proline betaine
1SW4 Crystal structure of ProX from Archeoglobus fulgidus in complex with trimethyl ammonium
1SW2 Crystal structure of ProX from Archeoglobus fulgidus in complex with glycine betaine
3MAM A molecular switch changes the low to the high affinity state in the substrate binding protein
AfProX
1SW5 Crystal structure of ProX from Archeoglobus fulgidus in the ligand free form
CenDH 1BG6 Crystal structure of the N-(1-D-carboxylethyl)-L-norvaline dehydrogenase from Arthrobacter sp.
strain 1C
OcDH 3C7C A structural basis for substrate and stereo selectivity in octopine dehydrogenase (OcDH-NADH-L-
arginine)
3C7D A structural basis for substrate and stereo selectivity in octopine dehydrogenase (OcDH-NADH-
pyruvate)
3C7A A structural basis for substrate and stereo selectivity in octopine dehydrogenase (OcDH-NADH)
AroE 2HK8 Crystal structure of shikimate dehydrogenase from Aquifex aeolicus
2HK9 Crystal structure of shikimate dehydrogenase from Aquifex aeolicus in complex with shikimate and
NADP+
1WXD Crystal structure of shikimate 5-dehydrogenase (AroE) from Thermus thermophilus HB8
2D5C Crystal structure of shikimate 5-dehydrogenase (AroE) from Thermus thermophilus HB8 in complex
with shikimate
2EV9 Crystal structure of shikimate 5-dehydrogenase (AroE) from Thermus thermophilus HB8 in complex
with NADP(H) and shikimate
3PHG Crystal structure of the shikimate 5-dehydrogenase (AroE) from Helicobacter pylori
3PHH Crystal structure of the shikimate 5-dehydrogenase (AroE) from Helicobacter pylori in complex with
shikimate and NADP(H)
3PHI Crystal structure of thesShikimate 5-dehydrogenase (AroE) from Helicobacter pylori in complex with
dehydroshikimate
DHQ-SDH 2GPT Crystal structure of Arabidopsis dehydroquinate dehydratase-shikimate dehydrogenase in complex
with tartrate and shikimate
2O7Q Crystal structure of the A. thaliana DHQ-dehydroshikimate-SDH in complex with dehydroshikimate
2O7S Crystal structure of the A. thaliana DHQ-dehydroshikimate-SDH in complex with dehydroshikimate,
NADP(H) and tartrate
QDH 3JYO Quinate dehydrogenase from Corynebacterium glutamicum in complex with NAD
3JYP Quinate dehydrogenase from Corynebacterium glutamicum in complex with quinate and NADH
3JYQ Quinate dehydrogenase from Corynebacterium glutamicum in complex with shikimate and NADH
2NLO Crystal structure of the quinate dehydrogenase from Corynebacterium glutamicum
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Glossary
Apo-protein/apo-enzyme
Enzymes that require a cofactor but do not have one bound are called apo-enzymes or apo-proteins. An apo-enzyme together
with its cofactor(s) is called a holoenzyme.
Affinity
The dissociation constant is commonly used to describe the affinity between a ligand and a protein, i.e. how tightly a ligand
binds to a particular protein. Ligand-protein affinities are influenced by non-covalent intermolecular interactions between the
two molecules such as hydrogen bonding, electrostatic interactions, hydrophobic and Van der Waals forces. They can also be
affected by high concentrations of other macromolecules, which causes macromolecular crowding. The smaller the dissociation
constant K d, the more tightly bound the ligand is, or the higher the affinity between ligand and protein.
Binary complex
A binary complex refers to a protein complex containing two different molecules which are bound together. In structural
biology, the term binary complex can be used to describe a crystal containing a protein with one small molecule bound, for
example the cofactor or the substrate; or a complex formed between two proteins.
Co-crystallization
Co-crystallization means that the protein solution is mixed with one or more ligand prior to the crystallization. Often the
protein-ligand mixture is preincubated before setting up the crystallization drops.
Cofactor
A cofactor is a non-protein chemical compound that is bound to a protein and is required for the protein's biological activity.
These proteins are commonly enzymes, and cofactors can be considered "helper molecules" that assist in biochemical
transformations. Cofactors are either organic or inorganic. They can also be classified depending on how tightly they bind to an
enzyme, with loosely bound cofactors termed coenzymes and tightly-bound cofactors termed prosthetic groups. Examples of
widespread cofactors are ATP, coenzyme A, FAD, and NAD+, vitamins or metal ions.
Kd
In chemistry, biochemistry, and pharmacology, a dissociation constant K d is a specific type of equilibrium constant that
measures the propensity of a larger object to separate (dissociate) reversibly into smaller components, as when a complex falls
apart into its component molecules, or when a salt splits up into its component ions.
KM
In biochemistry, Michaelis-Menten kinetics is one of the simplest and best-known models of enzyme kinetics. The Michaelis
constant K M is the substrate concentration at which the reaction rate is half of V max (which represents the maximum rate
achieved by the system, at maximum (saturating) substrate concentrations).
Intrinsic tryptophan fluorescence
Binding of ligands to proteins frequently causes changes to their three-dimensional structure. Exampes of this include the
binding of substrates, inhibitors, cofactors or allosteric modulators to enzymes or of hormons to receptors. If this structural
change has an effect on the environment of an intrinsic or extrinsic fluorophore in the protein, this can result in measurable
changes in the fluorescence spectrum. Provided that the fluorophore has a unique location in the protein, such changes of
fluorescence at a particular wavelength can be used to determine the dissociation constant (K d) of the protein for the ligand
where K d is a measure of the affinity of the protein for the ligand [50].
Isothermal Titration Calorimetry (ITC)
This technique is useful for protein concentrations in the range of mg/ml. A typical experiment involves measurement of heat
change as a function of addition of small quantities of a reagent to the calorimeter cell containing other components of the
system under investigation. For example, this reagent could be a protein ligand or substrate/ inhibitor of an enzyme. At the
beginning of the experiment, there is a large excess of protein compared to ligand. This means that Δ H values associated with
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each aliquot can be individually measured. Initially, these values are large but, as aliquots are progressively added, eventually
decrease to values similar to the Δ H of dilution of ligand into the solution in the calorimeter cell. The Δ H measured is the total
enthalpy change which includes heat associated with processes such as formation of noncovalent bonds between interacting
molecules and with other equilibria in the system such as conformational changes, ionization of polar groups (e.g.
deprotonation) and changes due to interactions with solvent. ITC provides a useful method for studying binding processes such
as those involving a protein and a ligand. It allows estimation of both the binding constant (K b) and of the dissociation
constant (K d) [50].
Ligand
In biochemistry a ligand is a substance (usually a small molecule), that forms a complex with a biomolecule to serve a biological
purpose. In the context of this chapter ligand is used as a more general expression for substrate, product or cofactor.
Ligand soaking
Ligand soaking means the addition of ligands into the mother liquid with preformed crystals. The idea is that the ligand
diffuses into the crystals and binds at the active site. This technique was initially used for the incorporation of heavy atoms into
protein crystals for phasing purposes.
Macro and Micro Seeding
During Macro Seeding the protein crystal is replaced into a freshly made mother liquid which allows the further enlargement of
the crystals size. In Micro Seeding a suspension of microcrystals is prepared by either resuspending or crushing a protein crystal
cluster or single crystals. These seeds are then used (often streaked through a new droplet of precipitant and fresh protein) to
serve a crystallization starting point.
Microbatch
Microbatch is a method in which the molecule to be crystallized is mixed with the crystallizing agents at the start of the
experiment. The concentration of the ingredients is such that supersaturation is achieved immediately upon mixing, thus the
composition and the volume of a trial remain constant and crystals will only form if the precise conditions have been correctly
chosen.
Occupancy
Occupancy means the degree of protein molecules in solution or in a crystal with bound ligand. If every second protein has
attached a ligand the occupancy is 50 %.
Substrate
In biochemistry, a substrate is a molecule upon which an enzyme acts. Enzymes catalyze chemical reactions involving the
substrate(s). In the case of a single substrate, the substrate binds with the enzyme active site, and an enzyme-substrate complex
is formed. The substrate is transformed into one or more products, which are then released from the active site. The active site
is now free to accept another substrate molecule. In the case of more than one substrate, these may bind in a particular order
to the active site, before reacting together to produce products.
Surface Plasmon Resonance (SPR)
SPR is an optical technique which depends on changes in refractive index or mass changes near metal surfaces. When
two surfaces, one a metal and the other a dielectric material are exposed to a beam of plane-polarized light of
wavelength, λ, a longitudinal charge density wave (a surface plasmon) is propagated along the interface between
them. This only happens when one of the surfaces is a metal and works best with silver, gold, copper and aluminium.
This is because metals contain free oscillating electrons called plasmons. When light traveling through an optically
dense medium such as glass arrives at an interface with a lower optical density (e.g. liquid), it is reflected back into the
more optically dense medium, a phenomenon called total internal reflectance. Any process altering n s (the refractive
index of the dielectric medium) can be sensitively detected by SPR so the technique has found applications in the
study of kinetics and thermodynamics of binding processes (e.g. protein-ligand, protein-protein) [50].
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Ternary complex
A ternary complex refers to a protein complex containing three different molecules which are bound together. In
structural biology ternary complex can be used to describe a crystal containing a protein with two small molecules
bound, for example cofactor and substrate; or a complex formed between two proteins and a single substrate.
Vapor diffusion Hanging or Sitting drop
Two of the most commonly used methods for protein crystallization fall under the category of vapor diffusion. These
are known as the hanging drop and sitting drop methods. Both entail a droplet containing purified protein, buffer,
and precipitant being allowed to equilibrate with a larger reservoir containing similar buffers and precipitants in
higher concentrations. Initially, the droplet of protein solution contains an insufficient concentration of precipitant for
crystallization, but as water vaporizes from the drop and transfers to the reservoir, the precipitant concentration
increases to a level optimal for crystallization. Since the system is in equilibrium, these optimum conditions are
maintained until the crystallization is complete [51].
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